.
Phylogica Limited (ASX:PYC) has raised $2.15 million through a share placement, just days after announcing it has completed the first stage of collaboration with the world's largest drugmaker, Pfizer Inc. (NYSE:PFE).
The peptide drug discovery company raised the funds through a placement to institutional and sophisticated investors at an issue price of $0.053 per share.
Phylogica plans to put the funds to enhancing its drug discovery infrastructure, investing in in-house programmes and supporting operational activities.
Earlier this week Phylogica announced it will receive its first milestone payment, for an undisclosed amount, from a collaboration with Pfizer to discover novel peptide-based vaccines.
The company currently has partnerships with Roche, Pfizer and MedImmune and is aiming to secure three new alliances by the end of fiscal 2012.
Phylogica reported a net loss of $3.6 million in the 2011 financial year.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.035(2.70%) |
Mkt cap ! $734.9M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.26 | $2.681M | 2.075M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3081 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.11pm 28/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |